Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Presynaptic calcium influx at the neuromuscular junction (NMJ) is a critical step in the process of neuromuscular transmission. When an action potential reaches the presynaptic terminal of a motor neuron, it causes membrane depolarization, activating voltage-gated calcium channels (VGCCs). This allows calcium ions (Ca2+) to enter the neuron, which is essential for triggering the fusion of synaptic vesicles with the presynaptic membrane and the subsequent release of acetylcholine into the synaptic cleft. The amount and timing of this calcium influx directly regulate neurotransmitter release, ultimately affecting muscle contraction strength. Proper function ensures effective neuromuscular transmission, while disruption can lead to diseases such as congenital myasthenic syndromes or autoimmune disorders like myasthenia gravis.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Presynaptic Calcium Influx at Neuromuscular Junction (N/A).